Race for the Mind - Welch, Daniel G
17,99 €
inkl. MwSt.

Versandfertig in über 4 Wochen
payback
9 °P sammeln
  • Broschiertes Buch

A story about the audacious challenge to defeat one of our greatest socio-economic threats - Alzheimer's disease - and how the medical community and the pharmaceutical industry rise to face it. The pressure and enormous stakes of the Race for the Mind expose the most noble and misguided aspects of our humanity. Dr. Darya Rostov, one of the greatest minds of a generation is stricken with Alzheimer's disease - she represents the 50 million people who are currently making their long journey into the night. Jack Callahan is the CEO of BioNeuro, a San Francisco biotech company developing what could…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
A story about the audacious challenge to defeat one of our greatest socio-economic threats - Alzheimer's disease - and how the medical community and the pharmaceutical industry rise to face it. The pressure and enormous stakes of the Race for the Mind expose the most noble and misguided aspects of our humanity. Dr. Darya Rostov, one of the greatest minds of a generation is stricken with Alzheimer's disease - she represents the 50 million people who are currently making their long journey into the night. Jack Callahan is the CEO of BioNeuro, a San Francisco biotech company developing what could be the first breakthrough for patients like Darya. Dr. Nathaniel Shah, a brilliant neurologist rises to run SNS, a rival company based in Geneva, Switzerland and hides a terrifying secret. The plot tracks Callahan and Shah, each driven by very different things and their struggle within themselves and with each other. It should be all about the patients like Rostov - but alas, we're all human - and that sometimes gets in the way.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dan has spent his entire career in the pharmaceutical business - decades of experience in multi-national pharmaceutical companies and smaller, US-based biotech companies. He has had a leadership role in the development and launch of several "block-buster" medicines; some the most prescribed in the world and others, break-through medicines for life-threatening diseases. Dan also worked in venture capital and private equity firms; essential sources of capital for developing new companies and medicines. His experience leading over a dozen successful biotech companies includes roles as CEO, Chairman of the Board, Board Director and senior advisor. Dan travels the world, loves his wife of 40 years, his two adult sons, fly fishing, ice hockey and everything about wine. He makes his home in California and Colorado.